Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective

about

Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective

Item

http://www.wikidata.org/entity/Q26752834

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective

@ast

Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective

@en

Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective

@nl

type

Item

label

Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective

@ast

Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective

@en

Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective

@nl

prefLabel

Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective

@ast

Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective

@en

Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective

@nl

P1476

Clinical utility of letrozole in the treatment of breast cancer: a Chinese perspective

@en

P2093

Dong-Xu He

http://www.w3.org/2001/XMLSchema#string

Xin Ma

http://www.w3.org/2001/XMLSchema#string

P2860

The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study.

Global cancer statistics, 2012

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Female breast cancer statistics of 2010 in China: estimates based on data from 145 population-based cancer registries

Tamoxifen--an update on current data and where it can now be used.

Tamoxifen for early breast cancer.

Breast cancer prevention with selective estrogen receptor modulators: a perspective.

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

Annual report on status of cancer in China, 2011

Lapatinib plus letrozole as first-line therapy for HER-2+ hormone receptor-positive metastatic breast cancer

P304

1077-84

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/OTT.S81087

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27042100

http://www.w3.org/2001/XMLSchema#string

P932

4780194

http://www.w3.org/2001/XMLSchema#string